Hydroxysafflor yellow A for ischemic heart diseases: a systematic review and meta-analysis of animal experiments
BackgroundHydroxysafflor yellow A (HSYA) possesses a variety of pharmacological activities which has been demonstrated to be effective against ischemic heart disease (IHD). This study aimed to comprehensively examine the efficacy and summarize the potential mechanisms of HSYA against IHD in animal m...
Saved in:
| Main Authors: | Tianshi Mao, Kaixin Jiang, Yanting Pang, Yi Pan, Wenhao Jia, Qun Gao, Qian Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1510657/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective effect of exercise induced metabolite-3 in ischemia-reperfusion injury
by: Zijie CHENG, et al.
Published: (2025-06-01) -
Downregulation of Gldc attenuates myocardial ischemia reperfusion injury in vitro by modulating Akt and NF-κB signalings
by: Lian Shuang, et al.
Published: (2025-01-01) -
Novel Aspects of Cardiac Ischemia and Reperfusion Injury Mechanisms
by: T. A. Yagudin, et al.
Published: (2019-01-01) -
Mechanical complications of myocardial infarction: basic aspects of pathogenesis and approaches to surgical treatment
by: L. D. Shengelia, et al.
Published: (2023-07-01) -
Ischemic preconditioning
by: Ristić-Anđelkov Anđelka, et al.
Published: (2005-01-01)